Back to Search Start Over

[Evaluation on the safety and immunogenicity of Canada split influenza virus vaccine].

Authors :
Hu YM
Fang HH
Gao GH
Zhang XF
Zhang YJ
Zhu SW
Zhu FC
Source :
Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi [Zhonghua Liu Xing Bing Xue Za Zhi] 2005 Jul; Vol. 26 (7), pp. 503-6.
Publication Year :
2005

Abstract

Objective: To evaluate the safety and immunogenicity of Canada split influenza virus vaccine.<br />Methods: Cluster samples were by randomly chosen and divided into split vaccination group and homoimported influenza vaccination group.<br />Results: After injection, fever-reaction and local reaction rates of 'trial' group were found as 3.69% and 1.75% respectively, but no statistical significance was found when compared with 'control' group. However the antibody positive rates of 'trail' and 'control' groupsappeared statistically significant (H1N1: 96.8% vs. 92.3%, H3N2: 95.8% vs. 90.2%, B: 52.3% vs. 62.3%). For geometric mean titer (GMT) of type H1N1, H3H2 and B antibody, 'trial' group and 'control' group increased 22.4, 16.8, 8.2 and 21.2, 12.5 and 7.4 times respectively. The antibody protective rates of type H1N1, H3N2 and B were 99%, 99% and 53.9% for 'trial' group, and 96.2%, 98.4% and 62.3% for 'control' but with no statistically significant difference.<br />Conclusion: Influenza split vaccine made in Shire company in Canada was safe and with good immunogenicity.

Details

Language :
Chinese
ISSN :
0254-6450
Volume :
26
Issue :
7
Database :
MEDLINE
Journal :
Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi
Publication Type :
Academic Journal
Accession number :
16335001